Skip to main navigation Skip to search Skip to main content

Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection

  • Tafadzwa Dzinamarira
  • , Mazen Almehmadi
  • , Ahad Amer Alsaiari
  • , Mamdouh Allahyani
  • , Abdulelah Aljuaid
  • , Abdulaziz Alsharif
  • , Abida Khan
  • , Mehnaz Kamal
  • , Ali A. Rabaan
  • , Amal H. Alfaraj
  • , Bashayer M. AlShehail
  • , Nouf Alotaibi
  • , Shams M. AlShehail
  • , Mohd Imran
  • University of Pretoria
  • Columbia University
  • Taif University
  • Northern Borders University
  • Johns Hopkins Aramco Healthcare
  • Alfaisal University
  • The University of Haripur
  • Ministry of Health, Saudi Arabia
  • Imam Abdulrahman Bin Faisal University
  • Umm Al-Qura University
  • King Abdulaziz University

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science